Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation

Genes and Development

Volumn 25, Issue 23, 2011, Pages 2480-2488

  Mullican, Shannon E ^a,b,c   Gaddis, Christine A ^a,b,c   Alenghat, Theresa ^a,b,c,d   Nair, Meera G ^b,c,d   Giacomin, Paul R ^b,c,d   Everett, Logan J ^a,b,c   Feng, Dan ^a,b,c   Steger, David J ^a,b,c   Schug, Jonathan ^a,b,c   Artis, David ^b,c,d   Lazar, Mitchell A ^a,b,c  

^a Department of Medicine   (United States)

^b Department of Genetics ^*  (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

Author keywords

Epigenomic; HDAC3; Macrophage

Indexed keywords

HISTONE; HISTONE DEACETYLASE 3; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EGG; EMBRYO; EPIGENETICS; FEMALE; GENE CONTROL; GENOME; INFLAMMATORY DISEASE; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PNEUMONIA; POLARIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHISTOSOMA MANSONI; TH2 CELL;

ANIMALS; EPIGENESIS, GENETIC; HISTONE DEACETYLASES; INTERLEUKIN-4; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED STRAINS; PNEUMONIA; SCHISTOSOMA MANSONI; TH2 CELLS;

EID: 82955247088     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.175950.111     Document Type: Article

References (51)

1. Anthony RM, Rutitzky LI, Urban JF Jr, Stadecker MJ, Gause WC. 2007. Protective immune mechanisms in helminth infection. Nat Rev Immunol 7: 975-987.
2. Barish GD, Yu RT, Karunasiri M, Ocampo CB, Dixon J, Benner C, Dent AL, Tangirala RK, Evans RM. 2010. Bcl-6 and NF-kB cistromes mediate opposing regulation of the innate immune response. Genes Dev 24: 2760-2765.
3. Classen A, Lloberas J, Celada A. 2009. Macrophage activation: Classical versus alternative. Methods Mol Biol 531: 29-43.
4. Clausen BE, Burkhardt C, ReithW, Renkawitz R, Forster I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8: 265-277.
5. Clayton AL, Hazzalin CA, Mahadevan LC. 2006. Enhanced histone acetylation and transcription: A dynamic perspective. Mol Cell 23: 289-296.
6. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: 3. doi: 10.1186/gb-2003-4-5-p3.
7. De Santa F, Narang V, Yap ZH, Tusi BK, Burgold T, Austenaa L, Bucci G, Caganova M, Notarbartolo S, Casola S, et al. 2009. Jmjd3 contributes to the control of gene expression in LPSactivated macrophages. EMBO J 28: 3341-3352.
8. Farnham PJ. 2009. Insights from genomic profiling of transcription factors. Nat Rev Genet 10: 605-616.
9. Feng D, Liu T, Sun Z, Bugge A, Mullican SE, Alenghat T, Liu XS, Lazar MA. 2011. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331: 1315-1319.
10. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
11. Ghigo E, Barry AO, Pretat L, Al Moussawi K, Desnues B, Capo C, Kornfeld H, Mege JL. 2010. IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation. PLoS ONE 5: e13561. doi: 10.1371/journal.pone.0013561.
12. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, Gregory L, Lonie L, Chew A, Wei CL, et al. 2010. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32: 317-328.
13. Gordon S, Martinez FO. 2010. Alternative activation of macrophages: Mechanism and functions. Immunity 32: 593-604.
14. Guenther MG, Barak O, Lazar MA. 2001. The SMRTand N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21: 6091-6101.
15. Haberland M, Montgomery RL, Olson EN. 2009. The many roles of histone deacetylases in development and physiology: Implications for disease and therapy. Nat Rev Genet 10: 32-42.
16. Halili MA, Andrews MR, Sweet MJ, Fairlie DP. 2009. Histone deacetylase inhibitors in inflammatory disease. Curr Top Med Chem 9: 309-319.
17. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589.
18. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, Leeto M, Kirsch R, Hall P, Mossmann H, et al. 2004. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635.
19. Herbert DR, Orekov T, Roloson A, Ilies M, Perkins C, O'Brien W, Cederbaum S, Christianson DW, Zimmermann N, Rothenberg ME, et al. 2010. Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol 184: 6438-6446.
20. Huang L. 2006. Targeting histone deacetylases for the treatment of cancer and inflammatory diseases. J Cell Physiol 209: 611-616.
21. Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, Allen RM, Carson WFT, Cavassani KA, Li X, Lukacs NW, et al. 2009. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114: 3244-3254.
22. Kang K, Reilly SM, Karabacak V, Gangl MR, Fitzgerald K, Hatano B, Lee CH. 2008. Adipocyte-derived Th2 cytokines and myeloid PPARd regulate macrophage polarization and insulin sensitivity. Cell Metab 7: 485-495.
23. Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW. 2008. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J 27: 1017-1028.
24. Lefterova MI, Steger DJ, Zhuo D, Qatanani M, Mullican SE, Tuteja G, Manduchi E, Grant GR, Lazar MA. 2010. Cellspecific determinants of peroxisome proliferator-activated receptor g function in adipocytes and macrophages. Mol Cell Biol 30: 2078-2089.
25. Li J, Wang J, Wang J, Nawaz Z, Liu JM, Qin J, Wong J. 2000. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19: 4342-4350.
26. Liu XS, Brutlag DL, Liu JS. 2002. An algorithm for finding protein-DNA binding sites with applications to chromatinimmunoprecipitation microarray experiments. Nat Biotechnol 20: 835-839.
27. Marmorstein R, Trievel RC. 2009. Histone modifying enzymes: Structures, mechanisms, and specificities. Biochim Biophys Acta 1789: 58-68.
28. Martinez FO, Helming L, Gordon S. 2009. Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 27: 451-483.
29. Montgomery RL, Potthoff MJ, Haberland M, Qi X, Matsuzaki S, Humphries KM, Richardson JA, Bassel-Duby R, Olson EN. 2008. Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice. J Clin Invest 118: 3588-3597.
30. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
31. Nair MG, Du Y, Perrigoue JG, Zaph C, Taylor JJ, Goldschmidt M, Swain GP, Yancopoulos GD, Valenzuela DM, Murphy A, et al. 2009. Alternatively activated macrophage-derived RELM-a is a negative regulator of type 2 inflammation in the lung. J Exp Med 206: 937-952.
32. Natoli G. 2010. Maintaining cell identity through global control of genomic organization. Immunity 33: 12-24.
33. Natoli G, Ghisletti S, Barozzi I. 2011. The genomic landscapes of inflammation. Genes Dev 25: 101-106.
34. Odegaard JI, Chawla A. 2011. Alternative macrophage activation and metabolism. Annu Rev Pathol 6: 275-297.
35. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, Subramanian V, Mukundan L, Ferrante AW, Chawla A. 2008. Alternative M2 activation of Kupffer cells by PPARd ameliorates obesity-induced insulin resistance. Cell Metab 7: 496-507.
36. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, Thompson RW, Cheever AW, Murray PJ, Wynn TA. 2009. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 5: e1000371. doi: 10.1371/journal.ppat.1000371.
37. Privalsky ML. 2004. The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66: 315-360.
38. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470: 279-283.
39. Roger T, Lugrin J, Le Roy D, Goy G, Mombelli M, Koessler T, Ding XC, Chanson AL, Reymond MK, Miconnet I, et al. 2011. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. Blood 117: 1205-1217.
40. Roh TY, Wei G, Farrell CM, Zhao K. 2007. Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns. Genome Res 17: 74-81.
41. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, et al. 2010. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11: 936-944.
42. Shakespear MR, Halili MA, Irvine KM, Fairlie DP, Sweet MJ. 2011. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol 32: 335-343.
43. Shin H, Liu T, Manrai AK, Liu XS. 2009. CEAS: Cis-regulatory element annotation system. Bioinformatics 25: 2605-2606.
44. Sullivan AL, Benner C, Heinz S, Huang W, Xie L, Miano JM, Glass CK. 2011. Serum response factor utilizes distinct promoter-and enhancer-based mechanisms to regulate cytoskeletal gene expression in macrophages. Mol Cell Biol 31: 861-875.
45. Sun Z, Singh N, Mullican SE, Everett LJ, Li L, Yuan L, Liu X, Epstein JA, Lazar MA. 2011. Diet-induced lethality due to loss of HDAC3 in heart and skeletal muscle. J Biol Chem 286: 33301-33309.
46. Tabas I. 2010. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 10: 36-46.
47. Tusher VG, Tibshirani R, Chu G. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci 98: 5116-5121.
48. Tuteja G, White P, Schug J, Kaestner KH. 2009. Extracting transcription factor targets from ChIP-seq data. Nucleic Acids Res 37: e113. doi: 10.1093/nar/gkp536.
49. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, Wagner RA, Greaves DR, Murray PJ, Chawla A. 2006. Oxidative metabolism and PGC-1b attenuate macrophagemediated inflammation. Cell Metab 4: 13-24.
50. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F, et al. 2009. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854-858.
51. Zhang J, Kalkum M, Chait BT, Roeder RG. 2002. The N-CoR- HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 9: 611-623.